OR4F17 | Olfactory receptor, family 4, subfamily F, member 17 | G-protein coupled receptors Predicted membrane proteins
| | | | | Not detected |
PPAP2C | Phosphatidic acid phosphatase type 2C | Enzymes Predicted membrane proteins
| | | | | Mixed |
MIER2 | Mesoderm induction early response 1, family member 2 | Transcription factors
| | | | | Expressed in all |
THEG | Theg spermatid protein | | | | | | Tissue enriched |
C2CD4C | C2 calcium-dependent domain containing 4C | | | | | | Group enriched |
SHC2 | SHC (Src homology 2 domain containing) transforming protein 2 | RAS pathway related proteins
| | | | | Mixed |
ODF3L2 | Outer dense fiber of sperm tails 3-like 2 | | | | | | Tissue enriched |
MADCAM1 | Mucosal vascular addressin cell adhesion molecule 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
TPGS1 | Tubulin polyglutamylase complex subunit 1 | | | | | | Mixed |
CDC34 | Cell division cycle 34 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Expressed in all |
GZMM | Granzyme M (lymphocyte met-ase 1) | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
BSG | Basigin (Ok blood group) | Blood group antigen proteins CD markers Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
HCN2 | Hyperpolarization activated cyclic nucleotide-gated potassium channel 2 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
POLRMT | Polymerase (RNA) mitochondrial (DNA directed) | Enzymes Mitochondrial proteins
| | | | | Expressed in all |
FGF22 | Fibroblast growth factor 22 | Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
RNF126 | Ring finger protein 126 | | | | | | Expressed in all |
FSTL3 | Follistatin-like 3 (secreted glycoprotein) | Cancer-related genes Disease related genes Predicted secreted proteins
| | | | | Expressed in all |
PRSS57 | Protease, serine, 57 | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
PALM | Paralemmin | | | | | | Mixed |
MISP | Mitotic spindle positioning | Cytoskeleton related proteins
| | | | | Tissue enhanced |
PTBP1 | Polypyrimidine tract binding protein 1 | Plasma proteins
| | | | | Expressed in all |
LPPR3 | Hsa-mir-3187 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
AZU1 | Azurocidin 1 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
PRTN3 | Proteinase 3 | Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ELANE | Elastase, neutrophil expressed | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CFD | Complement factor D (adipsin) | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
MED16 | Mediator complex subunit 16 | | | | | | Expressed in all |
R3HDM4 | R3H domain containing 4 | | | | | | Expressed in all |
KISS1R | KISS1 receptor | Disease related genes G-protein coupled receptors Potential drug targets Predicted membrane proteins Transporters
| | | | | Not detected |
ARID3A | AT rich interactive domain 3A (BRIGHT-like) | Transcription factors
| | | | | Tissue enhanced |
WDR18 | WD repeat domain 18 | Plasma proteins
| | | | | Expressed in all |
AC004528.1 | Uncharacterized protein | | | | | | Not detected |
GRIN3B | Glutamate receptor, ionotropic, N-methyl-D-aspartate 3B | FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
TMEM259 | Transmembrane protein 259 | Predicted membrane proteins
| | | | | Expressed in all |
CNN2 | Calponin 2 | Cytoskeleton related proteins Plasma proteins
| | | | | Expressed in all |
ABCA7 | ATP-binding cassette, sub-family A (ABC1), member 7 | Predicted membrane proteins Transporters
| | | | | Mixed |
HMHA1 | Histocompatibility (minor) HA-1 | Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
POLR2E | Polymerase (RNA) II (DNA directed) polypeptide E, 25kDa | RNA polymerase related proteins
| | | | | Expressed in all |
GPX4 | Glutathione peroxidase 4 | Enzymes Mitochondrial proteins Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
SBNO2 | Strawberry notch homolog 2 (Drosophila) | | | | | | Expressed in all |
STK11 | Serine/threonine kinase 11 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
C19orf26 | Chromosome 19 open reading frame 26 | Predicted membrane proteins
| | | | | Tissue enhanced |
ATP5D | ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit | Mitochondrial proteins
| | | | | Expressed in all |
MIDN | Midnolin | | | | | | Expressed in all |
CIRBP | Cold inducible RNA binding protein | Plasma proteins
| | | | | Expressed in all |
C19orf24 | Chromosome 19 open reading frame 24 | Predicted membrane proteins
| | | | | Expressed in all |
MUM1 | Melanoma associated antigen (mutated) 1 | | | | | | Expressed in all |
EFNA2 | Ephrin-A2 | Cancer-related genes Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
NDUFS7 | NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kDa (NADH-coenzyme Q reductase) | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
GAMT | Guanidinoacetate N-methyltransferase | Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Group enriched |